These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25600798)

  • 1. [Superficial spreading melanoma].
    Debarbieux S; Thomas L;
    Ann Dermatol Venereol; 2015 Jan; 142(1):66-9. PubMed ID: 25600798
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
    Gironi LC; Colombo E; Farinelli P; Giorgione R; Bozzola C; Ogliara P; Pasini B
    Int J Dermatol; 2015 Dec; 54(12):e553-5. PubMed ID: 26381259
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients.
    De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Grazzini M; Stanganelli I; Rossari S; Covarelli P; Massi D; Palmieri G
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):747-51. PubMed ID: 26223839
    [No Abstract]   [Full Text] [Related]  

  • 4. Germline CDKN2A mutations in childhood melanoma.
    Whiteman DC; Milligan A; Welch J; Green AC; Hayward NK
    J Natl Cancer Inst; 1997 Oct; 89(19):1460. PubMed ID: 9326917
    [No Abstract]   [Full Text] [Related]  

  • 5. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 6. CDKN2A: the IVS2-105A/G intronic mutation found in an Italian patient affected by eight primary melanomas.
    Majore S; Catricalà C; Binni F; De Simone P; Eibenschutz L; Grammatico P
    J Invest Dermatol; 2004 Feb; 122(2):450-1. PubMed ID: 15009729
    [No Abstract]   [Full Text] [Related]  

  • 7. [From gene to disease; from p16 to melanoma].
    Gruis NA; Bergman W
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ARFul truth about melanoma susceptibility genes.
    Merlino G
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):503-4. PubMed ID: 18713131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
    Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
    Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathway ahead in melanoma trials.
    Miller AJ; Markovic SN; Haluska P
    Oncology (Williston Park); 2009 May; 23(6):496, 498, 500. PubMed ID: 19544690
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.
    Soto JL; Cabrera CM; Serrano S; López-Nevot MA
    BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Clinical genetic testing for familial melanoma in Italy: a cooperative study".
    Amato A; Russo A; Adamo V; Cannavò SP
    J Am Acad Dermatol; 2010 Dec; 63(6):1099. PubMed ID: 21093666
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
    Gruis NA; Van der Velden PA; Bergman W; Frants RR
    Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines.
    Chan HH; Xiang L; Leung JC; Tsang KW; Lai KN
    Lasers Surg Med; 2003; 32(2):88-93. PubMed ID: 12561040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical genetic testing for familial melanoma in Italy: a cooperative study.
    Bruno W; Ghiorzo P; Battistuzzi L; Ascierto PA; Barile M; Gargiulo S; Gensini F; Gliori S; Guida M; Lombardo M; Manoukian S; Menin C; Nasti S; Origone P; Pasini B; Pastorino L; Peissel B; Pizzichetta MA; Queirolo P; Rodolfo M; Romanini A; Scaini MC; Testori A; Tibiletti MG; Turchetti D; Leachman SA; Bianchi Scarrà G;
    J Am Acad Dermatol; 2009 Nov; 61(5):775-82. PubMed ID: 19500876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CDKN2A mutation detected in Spanish melanoma pedigree.
    de Torre C; Martínez-Escribano J
    Exp Dermatol; 2010 Aug; 19(8):e333-5. PubMed ID: 20653773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell cycle: regulation and abnormalities in epidermal tumors].
    Heenen M
    Ann Dermatol Venereol; 1997; 124(6-7):452-6. PubMed ID: 9739908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy.
    Menin C; Vecchiato A; Scaini MC; Elefanti L; Funari G; De Salvo GL; Quaggio M; Tognazzo S; Agata S; Dalla Santa S; Montagna M; Alaibac M; Chiarion-Sileni V; D'Andrea E
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):728-30. PubMed ID: 21672182
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent tanning bed use: a risk factor for melanoma.
    Buckel TB; Goldstein AM; Fraser MC; Rogers B; Tucker MA
    Arch Dermatol; 2006 Apr; 142(4):485-8. PubMed ID: 16618869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.